Table 2 Effect of treatment on weight, depressive symptoms, general psychopathology, psychosocial functioning, and eating disorder symptoms in the full sample: results of the longitudinal multilevel mixed effects models

BMI (kg/m²)

1160

14.53 (14.42; 14.63)

17.11 (16.99; 17.24)

1.42 (1.29; 1.55)

BSI DEP

941

69.72 (69.07; 70.36)

61.29 (60.50; 62.08)

0.83 (0.70; 0.96)

BSI GSI

941

72.22 (71.56; 72.87)

61.92 (61.04; 62.80)

1.00 (0.86; 1.13)

GAF

564

39.95 (38.95; 40.95)

53.86 (52.51; 55.22)

1.15 (0.97; 1.33)

EDI-2 TO

935

0.97 (0.94; 1.00)

0.63 (0.60; 0.66)

0.76 (0.62; 0.89)

EDI-2 DT

935

1.52 (1.46; 1.58)

0.78 (0.72; 0.83)

0.80 (0.66; 0.93)

EDI-2 BU

935

0.42 (0.38; 0.47)

0.08 (0.06; 0.10)

0.49 (0.36; 0.62)

EDI-2 BD

935

1.61 (1.56; 1.66)

1.26 (1.20; 1.32)

0.46 (0.33; 0.59)

EDI-2 IN

935

1.07 (1.02; 1.11)

0.68 (0.64; 0.73)

0.54 (0.41; 0.67)

EDI-2 PE

935

1.19 (1.14; 1.24)

0.92 (0.88; 0.97)

0.37 (0.24; 0.49)

EDI-2 ID

935

0.82 (0.78; 0.86)

0.57 (0.54; 0.60)

0.40 (0.27; 0.53)

EDI-2 IA

935

0.98 (0.93; 1.02)

0.54 (0.50; 0.58)

0.67 (0.54; 0.80)

EDI-2 MF

935

0.93 (0.89; 0.97)

0.68 (0.64; 0.72)

0.39 (0.26; 0.51)

EDI-2 AS

935

0.86 (0.82; 0.90)

0.58 (0.54; 0.61)

0.46 (0.33; 0.59)

EDI-2 IR

935

0.44 (0.41; 0.47)

0.26 (0.24; 0.29)

0.42 (0.29; 0.55)

EDI-2 SI

935

0.95 (0.92; 0.99)

0.67 (0.63; 0.70)

0.48 (0.35; 0.61)